My ePortfolio Register   

Managing cytokine release syndrome

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.10.17
Views: 422
Rating:

Dr Charlotte Graham - King’s College London, London, UK

Dr Graham talks with ecancer at the ACP immunotherapy workshop about CRS, a side effect associated with recently approved CAR-T cell therapies.

She describes the presentation and pathways activated at the onset of cytokine release syndrome, and relates case details from one patient treated with tociluzumab and steroids.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence